Management of polycystic ovarian syndrome with homoeopathic intervention versus placebo -A randomized controlled pilot study

Central Council of Research in Homoeopathy0 个研究点目标入组 60 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•i.Female aged 18 to 36 years
•ii. Oligomenorrhea (Intermenstrual period of more than 35 days for 3 consecutive
•cycles)/amenorrhea for more than 3 months (two years after menarche)
•iii.Ultrasound findings of Polycystic ovaries
•The PCO should have at least one of the following: either 12 or more follicles measuring 2Â±9 mm in diameter or increased ovarian volume ( >10 cm3). If there is evidence of a dominant follicle ( >10 mm) or a corpus luteum, the scan should be repeated during the next cycle.
•Only one ovary fitting this definition or a single occurrence of one of the above criteria is sufficient to define the PCO.
•iv.Clinical evidence of hirsuitism (Ferriman score 8 and above)16 and/ or acne (acne global severity scale score 1 and above)
•v.Body mass index (BMI) 23 and above
•vi.Participants willing to adopt healthy diet and to take regular exercise (at least 30 minutes of exercise at least 5 days a week).
•vii.Written Informed consent from the patient

•i.History of diabetes mellitus
•ii.History of cushing disease
•iii.History of hyperprolactinemia
•iv.Untreated hypo or hyperthyroidism
•v.History of adrenal hyperplasia and adrenal tumor
•vi.Ovarian tumor
•vii.Hyperthecosis
•viii.Significant renal impairment
•ix.History of intake of drugs aldactone/ metformin or history of OCP use or intake of drugs known to interfere with carbohydrate metabolism prior 4 weeks before enrolment
•x.Pregnancy, breast feeding
•xi.Cases with other systemic diseases like cardiovascular, endocrinal diseases or Systemic infections or on other treatment therapies

发起方

Central Council of Research in Homoeopathy